Plastic Combination Conveyor Chain Increases Wear Life Without Lubrication - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Plastic Combination Conveyor Chain Increases Wear Life Without Lubrication

Equipment and Processing Report

FBchain
Image courtesy FB Chain

A corrosion-resistant, plastic combination (PC) conveyor chain from FB Chain is designed for pharmaceutical manufacturing and meets EU hygiene standards. The chain is constructed from detection-grade engineering plastic inner links, supported by 304-grade stainless-steel bearing pins and outer link plates. The PC chain matches the strength of standard stainless-steel chain but has a much lower friction coefficient, eliminating the need for lubrication and increasing wear life. The PC chain is also quieter and lighter than stainless-steel chain. The bushed design of the plastic inner link eliminates the risk of residue becoming trapped between the chain components in wash-down applications. FB Chain’s PC chain is dimensionally interchangeable with stainless-steel chain; no adjustments to sprockets or other existing conveyor components are required to accommodate it.

Source: FB Chain

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Equipment and Processing Report,
Click here